Washington D.C, 3 August 2022 (TDI): The World Bank has approved operations totaling $10.1 billion to support the rollout of the COVID-19 vaccination in 78 countries.
As of June 30 2022, @WorldBank has approved operations supporting COVID vaccine rollout in 78 countries, amounting $10.1b. We’ve financed 617m doses, 433m of which already delivered. We’ll continue to accelerate purchase, delivery & administration. https://t.co/UlHlAdltQz pic.twitter.com/tKW2Q2kGCt
— World Bank (@WorldBank) August 3, 2022
The World Bank Group is leading the largest immunization campaign yet to halt the COVID-19 epidemic. Emergency actions to prevent, identify, and respond to COVID-19 have reached over 100 countries as part of the initiative, which has also strengthened systems for public health preparation.
In addition, the World Bank funded 617 million doses, 433 million of which have been administered. Purchase, delivery, and administration will all continue to be expedited.
Aim of World Bank for Covid-19
The quick mobilization of vaccine finance by the World Bank serves to enable the deployment and purchase of vaccines at fair and reasonable prices.
Moreover, An incentive to supply developing economies with vaccines at competitive pricing is provided by such a commitment. In addition, to assist IDA and IBRD nations, the World Bank Group is cooperating on a worldwide scale with COVAX, WHO, UNICEF, and other partners.
World Bank
The World Bank resembles a cooperative with 189 members. In addition, A Board of Governors, the World Bank’s top decision-makers, represents these member nations or shareholders.
It is distinct international cooperation consisting of five institutions that aim to find a long-term solution to the world’s problems of poverty and inequality.
World Bank support for Covid-19 Vaccination
According to World Bank, the Bank’s Board of Executive Directors adopted a $6 billion Global COVID-19 Response Program (SPRP) on April 2, 2020, during the initial COVID-19 response phase.
On October 13, 2020, the World Bank Board approved an additional $12 billion in funding to the SPRP for developing countries to support the purchase and distribution of COVID-19 vaccines in recognition of the demand for these vaccines.
On June 30, 2021, President Malpass, President of World Bank, announced an increase in funding for the COVID-19 vaccine from $12 billion to $20 billion.
